针对日本脑炎病毒的抗病毒药物的最新进展
Yongzhe Zhu1, Shenglin Chen2, Qilin Lurong3
1Department of Microbiology, Faculty of Naval Medicine, Naval Medical University, Shanghai 200433, China.
Viruses
|May 27, 2023
概括
尽管有疫苗,日本脑炎病毒 (JEV) 仍然是一个威胁. 本综述探讨了针对JEV和宿主因子的抗病毒药物,以及用于有效治疗日本脑炎 (JE) 的免疫调节药物.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 日本脑炎病毒 (JEV) 是由Culex蚊子传播的,自1935年以来造成了人类健康的重大威胁.
- 目前的JEV疫苗没有破坏自然传播,对于日本脑炎 (JE) 没有特定的抗病毒药物存在.
- 致病病毒感染涉及复杂的病毒与宿主细胞相互作用,突出显示了对新型治疗策略的需求.
研究的目的:
- 审查针对JEV.的现有和新兴抗病毒策略.
- 探索调节宿主因子和免疫反应的治疗方法.
主要方法:
- 对针对JEV元素的抗病毒药物的文献综述.
- 对调节天生的免疫力,炎症,亡和亡的宿主导疗法的分析.
主要成果:
- 确定了针对JEV复制和组装的抗病毒药物.
- 突出针对宿主的药物,调节免疫反应和细胞死亡途径.
- 强调了联合抗病毒和宿主保护策略的潜力.
结论:
- 针对JEV和宿主因子的新型抗病毒药物对于JE治疗至关重要.
- 调节宿主免疫和细胞死亡途径提供了有前途的治疗途径.
- 开发具有抗病毒和宿主保护作用的药物是有效管理JE的关键.
相关概念视频
Subviral Agents
51
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
51
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
354
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
354


